Industrial Chemicals – About Us
Overview of Business
DFPCL is a leading manufacturer of industrial chemicals in India. It specializes in manufacturing high quality chemicals that surpass domestic and international quality standards. The chemicals manufactured can be customized for specific industries and precise applications, thus providing solutions to cater to the exact requirements of its customers. The products cater to various sectors such as pharmaceuticals, agrochemicals, drugs and dye intermediates, refining of precious metals, resin, textile, fertiliser among others.
The company is a leading manufacturer of Nitric Acid, Iso Propyl Alcohol (IPA), Liquid Carbon Dioxide and Methanol. To cater to the domestic requirements and to maintain its leadership position, DFPCL also imports and supplies acetone, ammonia, IPA, methanol, phenol and toluene.
All products conform to world-class quality standards and are preferred brands among various sectors. The Food and Drugs Administration, Govt. of India has issued the FDA license for drummed IPA as conforming to IP, BP, PHEuro, USP standards. Under this license, other products like Methanol, Carbon dioxide and Nitric Acidcan also be included.
Iso Propyl Alcohol produced at Taloja plant is of international quality and standards and meets stringent norms of the pharmaceutical and cosmetics industry.
In the Nitric Acid market, DFPCL has developed various customer-led products and grades. The Nitric Acid complex at DFPCL is the largest of its kind in all of Asia. Consistent supply of natural gas via DFPCL’s own gas pipeline guarantees an uninterrupted feed stock for ammonia assuring product quality and availability. Further, DFPCL’s combined Nitric Acid facility of around 8,31,600 MT is supported byon-site ammonia thusensures reliable year – round supply.
DFPCL will enhance its nitric acid production capacities by setting up a greenfield project in Dahej, Gujarat, with an estimated investment of Rs 550 crores. Most of the company’s manufacturing facilities, which include chemicals, TAN and fertilisers, are based in Taloja and this would be its first foray into Gujarat state. The project, land for which has already been acquired, is scheduled to be completed by H2 of 2018.
List of Manufactured products:
- Iso Propyl Alcohol (IPA)
- Dilute Nitric Acid (60%)
- Concentrated Nitric Acid (98%)
- Strong Nitric Acid (64%, 68% and 72%)
- Liquid Carbon Di-Oxide
DFPCL is the only manufacturer and supplier of Isopropyl Alcohol (IPA) in India with an installed capacity of 70,000 MTPA. DFPCL manufactures IPA through an extremely efficient and environment friendly, direct hydration process, producing a colorless product of high purity, with no undesirable odor or by-product formation. The product meets international quality standards for use in pharmaceuticals, coatings and inks, specialty chemicals and cosmetics. For critical applications in the pharma sector, DFPCL offers IPA conforming to stringent standards such as IP, BP, Chinese Pharmacopeia USP, to name a few.
DFPCL has a fully automated drumming facility for catering to small consumers and for meeting the increasing demand from neighboring countries for exports. Our product has been well accepted in various markets such as USA, EU, AFRICA, MIDDLE EAST and FAR EAST. DFPCL also offers GMP Grade IPA which is Benzene free which meets the monographs of all the international pharmacopoeias.
To maintain its leadership position and to cater to the growing domestic demands, DFPCL also imports and supplies Isopropyl Alcohol from other global producers. IPA is widely used in the pharma industry as a solvent in manufacture of bulk drugs, intermediates and formulations. IPA is also used in printing inks, coatings and producing derivatives such as Isopropyl Acetate.
DFPCL’s state-of-the-art Adolf PlinkeGmbh technology based plant at Taloja is the largest integrated nitric acid plant across South East Asia which conforms with international standards. The company manufactures three grades of nitric acid which include dilute nitric acid (DNA), strong nitric acid (SNA) and concentrated nitric acid (CNA). In addition to these, DFPCL also has the capability of customizing grades to cater to specific requirements of its customers.
To serve its customer better and ensure just-in-time delivery, the company has set up another state-of-the-art green field plant in Dahej, Gujarat with an investment of Rs. 550 crores, with CNA annual production capacity of 92400 MT. and DNA annual production capacity of 148500 MT. The new facility has started commercial production in April 2019.
One of the largest producers of Dilute Nitric Acid (60%) in India with an installed capacity of 6,93,000 MTPA, DFPCL incorporates internationally renowned know-how and expertise from Weatherly Inc., USA, guaranteeing consistent, high purity DNA.
One of the largest producers of Concentrated Nitric Acid (CNA) in India with an installed annual capacity of 1,38,600 metric tonnes (MT), DFPCL guarantees high purity CNA with technology from Adolf PlinkeGmbh, Germany, one of the world’s best expertise and technology.
DFPCL has introduced NA 64%, 68% and 72% to meet the specific requirements of the industry and has been well received in the market.
DFPCL is one of the largest producers of Methanol in India with an installed capacity of 1,00,000 MTPA at Taloja, with a safe storage facility of 5,000 MT on site, ensuring uninterrupted supply.
State of the art technology from ICI/Davy McKee, UK guarantees consistent high purity methanol meeting the requirements of ASTM D 1152 1989 and IS 517:1986 (Pure Grade).
DFPCL is one of the leading suppliers of Liquid Carbon Dioxide with an installed annual capacity of 66,000 MT for Liquid Carbon Dioxide. Liquid Carbon Dioxide produced by the company ‘food grade’ certified and is supplied to various beverage manufacturers.
List of traded products:
DFPCL imports and supplies Acetone from various manufactures globally. The product is readily available on the east coast as well as on the west coast ports of India. The company has the capability of providing Benzene free Acetone. As a solvent, Acetone finds application in Pharma Industry, in production of rubber chemicals, in defense applications, for production of MMA etc.
DFPCL imports Toluene from world class producers with an ability to source and supply Benzene free Toluene and also Nitration grade Toluene. Toluene finds applications as a solvent in pharma and other industries, fuel and in nitro-aromatics. It is also used in the production of TDI, one of the major precursors of Polyurethanes.
In-order to meet challenges of highly competitively market DFPCL adopted flexible strategy of offering imported and domestically manufactured Methanol, thereby assuring customers the best of both options. Methanol finds wide range of applications in its derivatives such as formaldehyde, in fuel building and as a solvent.
Being India’s leading Ammonia importer, DFPCL offers regular volumes of Ammonia at JNPT port on West Coast.
DFPCL offers molten and hydrated Phenol imported from world-class manufacturers. Phenol finds immense applications in production of Phenol formaldehyde resins used in plywood and decorative laminates. Phenol is also used in Agro-chemicals, Foundry chemicals, in Pharma applications.
PLEASE READ THIS NOTICE CAREFULLY. IT APPLIES TO ALL PERSONS WHO VIEW THIS WEBSITE. VIEWING THIS INFORMATION MAY NOT BE LAWFUL IN CERTAIN JURISDICTIONS. PLEASE NOTE THAT THE DISCLAIMER SET OUT BELOW MAY BE ALTERED OR UPDATED. YOU SHOULD READ IT IN FULL EACH TIME YOU VISIT THE WEBSITE. BY ACCESSING THIS INFORMATION ON THIS WEBSITE, YOU AGREE TO THE TERMS AND CONDITIONS BELOW, INCLUDING ANY MODIFICATIONS THAT MAY BE MADE TO THEM FROM TIME TO TIME.
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED IN THE UNITED STATES OR OTHER JURISDICTIONS OUTSIDE INDIA.
The following disclaimer applies to the documents of Deepak Fertilisers and Petrochemicals Corporation Limited (the “Company”, and such documents, the “Documents” and each, a “Document”) hosted on this website in connection with the Company’s issue of equity shares on a rights basis (the “Issue” and the “Equity Shares”, respectively). The Documents have been made available on this website in electronic form solely to comply with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and SEBI Circular No. SEBI/HO/CFD/DIL2/CIR/P/2020/78 dated May 06, 2020 read with the SEBI Circular SEBI/HO/CFD/DIL1/CIR/P/2020/136 dated July 24, 2020. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Documents. By accessing the Documents, you agree to follow the following terms and conditions, including any modifications to them from time to time. References to the Company herein include its subsidiaries, affiliates, and associate, as applicable, which are consolidated in its accounts.
NOTHING HEREIN CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO.
The contents of the Documents are for your information only. No part of the contents herein shall be copied or duplicated in any form by any means or redistributed. Neither the Company, nor any of its representatives or agents are soliciting any action based on any of the information contained on this website, including the Documents, and such information should not be construed as an offer, or invitation or offer to sell or the solicitation of any offer to buy or subscribe for or purchase any security. Neither the Company, nor any of its representatives or agents represents that the contents of the Documents are accurate or complete. The information contained in the Documents may not be updated since its original publication date and may not reflect the latest updates.
The Documents may contain statements about future events and expectations that constitute forward-looking statements. There can be no assurance that the results and events contemplated by the forward-looking statements contained there will in fact occur. The Company, its Directors, the Lead Manager or any of their respective affiliates do not make any representation or warranty, express or implied, as to, and do not accept any responsibility or liability with respect to, the fairness, accuracy, completeness or correctness of any information or opinion in the Documents.
Please note that because of restrictions imposed by applicable law or regulation on soliciting securities business in various jurisdictions, subscription to the Issue will not be permitted to residents of certain jurisdictions. The information contained in this portion of our website and the Documents are not intended to be, and should not be, viewed by any person in the United States or in any other jurisdiction outside India where the offer and sale of the securities is not permitted under the laws of such jurisdictions. The Documents are not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would not be permissible under or in violation of any applicable law or regulation; or (b) the Company would by virtue of such distribution become subject to new or additional registration requirements.
The information on this website and the Documents are directed solely to Eligible Equity Shareholders of the Company as on the Record Date, as contemplated in the Documents. This website and the Documents should not be reproduced, transmitted or distributed to any other person.
The Rights Entitlements and the Equity Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “US Securities Act”), or any U.S. state securities laws and may not be offered, sold, resold or otherwise transferred within the United States or the territories or possessions thereof (the “United States” or “U.S.”), except in a transaction exempt from the registration requirements of the US Securities Act. The Rights Entitlements and the Equity Shares are being offered and sold in offshore transactions outside the United States in compliance with Regulation S under the US Securities Act to existing shareholders located in jurisdictions where such offer and sale of the Equity Shares and Rights Entitlements are permitted under applicable law.
The Documents do not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If you have gained access to this website and the Documents contrary to any of the restrictions herein, you are not authorized and will not be able to purchase any of the securities described in the Documents.
Any potential investor should note that investment in the Equity Shares involves a high degree of risk. For details, potential investors should refer to the Letter of Offer issued by the Company in connection with the Issue, including the section titled “Risk Factors”.
Neither the Company, nor any of its representatives or agents accept any liability whatsoever, direct or indirect, that may arise from the use of the information contained on this website or the Documents. Nothing on this website or in the Documents constitutes a recommendation by the Company or its representatives or agents to subscribe to or buy or sell any securities.
The Company has taken all necessary steps to ensure that the contents of the Document as appearing on this website are identical to the Document filed with the relevant regulatory authorities in India. However, you are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither the Company, nor any of its representatives or agents accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. None of the Company, its representatives or its agents will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
You acknowledge that access to the Documents is intended for use by you only and you agree not to forward the Documents on to any other person, in whole or in part, or otherwise provide access via e-mail or otherwise to any other person.
You are accessing this website at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses and other items of a destructive nature. Neither the Company, the Lead Manager nor any of their affiliates their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in making this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access, or use of the website or these materials. It is your responsibility to take precautions to ensure that it is free from viruses and other items of a destructive nature.
The Documents may not be downloaded, delivered, forwarded or distributed, electronically or otherwise, in whole or in part, to any other person and may not be reproduced in any manner whatsoever. Any downloading, forwarding, delivery, distribution or reproduction of the Documents in whole or in part is unauthorized. Failure to comply with this disclaimer may result in a violation of the applicable laws.
YOU HEREBY REPRESENT THAT YOU ARE ACCESSING THE DOCUMENTS ON THIS WEBSITE ON THE BASIS THAT YOU ARE A PERSON INTO WHOSE POSSESSION THESE DOCUMENTS MAY BE LAWFULLY DELIVERED IN ACCORDANCE WITH ALL APPLICABLE LAWS. IF ANY APPLICABLE LAWS DO NOT PERMIT TO ACCESS THE WEBSITE OR VIEW THE DOCUMENTS ON THIS WEBSITE OR YOU ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE DOCUMENTS, PLEASE EXIT THIS WEBSITE.
PLEASE NOTE THAT THE DOCUMENTS USED FOR SUBSCRIPTION TO THE ISSUE IN CONTRAVENTION OF THE ABOVE WILL BE REJECTED WITH NO RECOURSE TO THE COMPANY OR ITS REPRESENTATIVES OR AGENTS.
[I certify that I am authorized to access this site]
To access this information, you must confirm by pressing on the button marked “I Confirm” that, at the time of access, you (a) are located and resident in India and (b) are not a resident of the United States and you are not located inside the United States and (c) are eligible to participate in this Issue. If you cannot make this confirmation, you must press the button marked “I Do Not Confirm”.